All 26 members of the Thai women’s national volleyball team were diagnosed with the Chinese Kexing vaccine

A medical staff member shows a box of the Chinese Communist Party’s domestic national vaccine.

As the Communist Party’s virus epidemic continues to rage, Beijing authorities are engaged in vaccine diplomacy, but scandals over Chinese-made vaccines are rampant. The Thai national women’s volleyball team was scheduled to participate in the World Volleyball League on the 25th, and was given the Chinese Kexing vaccine before the match, but now 26 people have been tested and confirmed.

The Thai Volleyball Association released a statement on the 12th, saying that a total of 26 people from Thailand’s national women’s volleyball training camp were diagnosed with the Chinese Communist virus and had to withdraw from the upcoming World Volleyball League to be held in Italy at the end of this month.

After four trainers who assisted the team in preparing for the tournament were diagnosed with the virus on the 11th, a total of 37 people, including women’s volleyball players, coaches and staff, were tested for nucleic acid on the same day, of which 22 were confirmed and sent to the hospital on the 12th.

Since April 20, the Thai women’s volleyball team has been training in Phra Thong Province, west of Bangkok, to prepare for the World Volleyball League, and on April 29, the women’s volleyball team and staff received the first dose of the Chinese Kexing vaccine.

While 22 Thai volleyball players tested positive for the virus and were sent to hospital for observation and treatment, four more were diagnosed and the number has now risen to 26.

The Thai Volleyball Association said in a statement that due to the high number of confirmed cases, the Thai women’s volleyball team had to decide to withdraw from the World Volleyball League and notify the FIVB.

Thailand’s National Epidemic Center said it is clear that even vaccination is no guarantee against infection, and hopes that all parties will take this as a warning not to relax their preventive measures because of vaccination.

As the Communist Party’s virus epidemic continues to rage, the Chinese authorities are pushing for “vaccine diplomacy,” but the safety and effectiveness of Chinese-made vaccines are in question. In recent months, there have been frequent reports of confirmed cases of vaccination with the CCP-made vaccine.

Pakistan, which began using the Chinese-made vaccine in early February, is currently experiencing a third wave of the outbreak, with the national infection rate rising to 11 percent, the highest level since the outbreak began.

Pakistan’s President Arif Alvi and Prime Minister Imran Khan have both tested positive for the virus after being vaccinated with the Chinese Communist Party’s national vaccine.

Most people in Brazil, Chile, and Turkey have been vaccinated with the Chinese Communist Party’s domestic vaccine, but the number of confirmed cases in these countries is rising daily.

Former Peruvian President Martin Vizcarra and his wife were among the first foreign dignitaries to receive the Chinese-made vaccine, and on April 25, Vizcarra tweeted, “Despite taking the necessary protective measures to avoid bringing the virus home, both my wife and I have tested positive.”

Chinese vaccine expert Taurina revealed on January 5 on social media platforms that Chinese vaccines are “the most unsafe vaccines in the world” with up to 73 side effects after receiving the national vaccine.

On March 5, Peruvian television station “WillaxTV” made public the “Universidad Peruana Cayetano Heredia” (University of Cayetano Heredia) and China National Pharmaceuticals’ (SinoPharm) collaboration on the Chinese vaccine. The data from the clinical trial of the CCP virus vaccine, conducted by the Universidad Peruana Cayetano Heredia and SinoPharm, were released.

The trial data showed that the inactivated vaccine developed by the Wuhan Institute of Biological Products of China National Pharmaceutical Group was only 11.5% effective against the CCP virus, while the vaccine developed by the Beijing Institute of Biochemistry was 33% effective.